These drugs haven’t been directly compared in clinical studies, but reports have found each Zoladex and Lupron Depot to be efficient for the palliative therapy of Highly developed prostate most cancers.Publisher’s note Springer Character continues to be neutral with regard to jurisdictional promises in printed maps and institutional affiliation